National Pension Service Increases Holdings in The Clorox Company $CLX

National Pension Service boosted its position in The Clorox Company (NYSE:CLX) by 21.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,635 shares of the company’s stock after buying an additional 1,539 shares during the quarter. National Pension Service’s holdings in Clorox were worth $1,037,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in CLX. Simplicity Wealth LLC boosted its position in Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after acquiring an additional 11,198 shares in the last quarter. Raymond James Financial Inc. raised its position in shares of Clorox by 15.6% in the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after acquiring an additional 36,352 shares in the last quarter. Nuance Investments LLC lifted its stake in shares of Clorox by 182.5% in the 2nd quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock valued at $101,832,000 after purchasing an additional 547,839 shares during the period. Nordea Investment Management AB boosted its position in shares of Clorox by 16.3% during the second quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock valued at $57,827,000 after purchasing an additional 68,026 shares in the last quarter. Finally, AlphaQuest LLC grew its stake in Clorox by 109.4% in the first quarter. AlphaQuest LLC now owns 11,873 shares of the company’s stock worth $1,748,000 after purchasing an additional 6,203 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 0.7%

Shares of NYSE CLX opened at $103.52 on Friday. The firm’s 50 day moving average price is $117.67 and its 200-day moving average price is $123.61. The Clorox Company has a 52-week low of $103.43 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market cap of $12.63 billion, a PE ratio of 15.88, a P/E/G ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 77.86%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 28th. Wells Fargo & Company lowered their price target on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. Bank of America dropped their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Rothschild & Co Redburn decreased their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $125.69.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.